The Sherwin-Williams Company
SHWLast close · Oct 16, 2026335.20−1.72 (−0.51%)
Market cap$81.4B
12 firms' latest targets, last 90 days: median $393.50 ($340.00–$420.00), 17% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-12 | Barclays | $348.00 | — | +4% |
| 2026-10-09 | RBC Capital | $392.00 | ▲ 1% | +17% |
| 2026-10-06 | Melius Research | $367.00 | — | +9% |
| 2026-10-05 | UBS | $363.00 | ▼ 7% | +8% |
| 2026-09-25 | Wells Fargo | $340.00 | ▼ 6% | +1% |
| 2026-09-24 | Mizuho Securities | $396.00 | ▼ 3% | +18% |
| 2026-08-24 | D.A. Davidson | $400.00 | — | +19% |
| 2026-08-03 | Guggenheim | $400.00 | — | +19% |
| 2026-07-29 | Goldman Sachs | $420.00 | — | +25% |
| 2026-07-29 | BMO Capital | $405.00 | ▲ 14% | +21% |
| 2026-07-29 | Morgan Stanley | $395.00 | — | +18% |
| 2026-07-28 | Jefferies | $375.00 | — | +12% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2022reported | $22.1B | +11% | $7.72 | +11% | est. $22.2B+0% | est. $8.71 | 6 |
| 2023reported | $23.1B | +4% | $9.25 | +20% | est. $23.0B+0% | est. $10.33 | 15 |
| 2024reported | $23.1B | +0% | $10.55 | +14% | est. $23.1B+0% | est. $11.30 | 14 |
| 2025reported | $23.6B | +2% | $10.27 | -3% | est. $23.5B+0% | est. $11.37 | 15 |
| 2026 | $25.1B | +7% | $12.10 | +6% | $25.0B–$25.2B | $12.00–$12.16 | 19 |
| 2027 | $26.2B | +4% | $13.53 | +12% | $25.6B–$26.5B | $13.09–$13.98 | 19 |
| 2028 | $27.5B | +5% | $15.01 | +11% | $26.8B–$28.2B | $13.91–$16.29 | 17 |
| 2029 | $28.9B | +5% | $16.55 | +10% | $28.4B–$29.3B | $16.18–$16.83 | 13 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.